Biomed 2018 – Israeli Life science and technology week2018-05-13T11:33:52+00:00

About MIXiii-BIOMED 2018

Dear Friends and Colleagues,

It is our honor and pleasure to invite you to participate in the 17th MIXiii-BIOMED 2018 Conference and Exhibition, to be held May 15-17, 2018 in Tel AvivIsrael.

This year we will explore and aim to fuel the innovations and trends that are shaping the future of healthcare systems and life sciences. The conference will be divided into 9 tracks:

  • Digital Health, IoT, and Big Data – New Armamentarium in Medicine
  • Next Generation Oncology Treatments
  • Brain Health
  • Personalized Diagnostics and Treatments
  • Fighting Rare Genetic Diseases Using Novel Therapeutic Approaches
  • Nanomedicine and its Role in New Medical Therapeutics
  • From Academia Research to Industry
  • Cutting Edge Medical Device Technologies: Metabolic, Ophthalmology
  • Novel Clinical Trial Designs and Technologies to Accelerate Drug Development

As we envision and analyze our projections for the future of healthcare systems, we should address ways to diagnose and treat patients by utilizing next generation methods. With the goal of improving the way we treat, prevent and cure diseases, we should consider innovations in precision and targeted medicine genetics, personal diagnosis, treatment and monitoring.

Read More

When & Where

  • Follow us on:

    color-facebook-128   color-twitter-128   google-plus-circle   color-linkedin-128  

  • Articles related to the field:


INVITED SPEAKERS (Preliminary List)

Arie S. Belldegrun, MD, FACS
Founder, Kite Pharma; Executive Chairman & Co-Founder, Allogene Therapeutics

Francois Maisonrouge
Senior Managing Director, Evercore Partners

Bruce R. Rosengard, MD
Vice President, External Innovation, Medical Devices, Johnson and Johnson Medical Devices

Paul R. Biondi
Senior Vice President, Head of Business Development, Bristol-Myers Squibb

Philip Nelson
Director of Engineering at Google Research

Anat Naschitz
Managing Director, Orbimed Advisors

Allen Kamer
Managing Partner, OurCrowd Qure

Prof. David Sidransky, MD
Johns Hopkins School of Medicine and Israel Biotech Fund, Co-Founder and General Partner

Tetsuyuki Maruyama, PhD
Chief Scientific Officer, Dementia Discovery Fund, SV Life Sciences Managers

Iris Grossman, PhD
Chief Scientific Officer, Camp4 Therapeutics

Prof. Simon Benita, PhD
Head of Nano Delivery Systems, Hebrew University of Jerusalem

Gil Granot-Mayer
CEO, Yeda R&D – Technology Transfer, Weizmann Institute of Science

Irit Yaniv, MD
General Partner, Accelmed

Barak Azmon, MD
Ophthalmic Entrepreneur

Yael Weiss, MD, PhD
Vice President Business Development, Ultragenyx

Varda Shalev, MD, MPH
Managing Director, Morris Kahn & Maccabi Research and Innovation Institute at Maccabi Health Care Services

Michael L. Salgaller, PhD
Supervisor, Invention Development and Marketing Unit (IDMU), Technology Transfer Center, National Cancer Institute, National Institutes of Health

Prof. Nir Giladi, MD
Director, Neurology Division, Tel Aviv Sourasky Medical Center

Prof. Gideon Rechavi, MD, PhD
Sheba Cancer Research Center

Prof. Dror Harats, MD
Chief Executive Officer, Vascular Biogenics

Shai Rosenberg, MD
Neuro-Oncology and head of Cancer Computational Biology laboratory, Hadassah – Hebrew University Medical Center

Miro Venturi, PhD
Global Head – Diagnostics Biomarkers, F. Hoffmann-La Roche Ltd.

Randy Prebula
Partner, Hogan Lovells, Washington, D.C.

David Fenstermacher, PhD
Vice President R&D-Bioinformatics, Medimmune

David Cassak
Managing Partner, Innovation In Medtech

Daphna Laifenfeld, PhD
Chief Strategy Officer, Ibex Medical Analytics

Erhan Bilal, PhD
IBM T.J. Watson Research / Computational Biology Center

Anand Subramony, PhD
Vice President, Novel Product Technologies, MedImmune

Tauhid Ali, PhD
Vice President and Head of TAK-celerator, Takeda

Zeev Zehavi
Vice President of Venture Investments, Johnson & Johnson Innovation – JJDC, Inc. (JJDC)

Elie Lobel
Chief Executive Officer, Orange Healthcare

Prof. John Gallacher
Director, Dementia Platform UK,

Michael Martin, PhD
Global Head, Takeda Ventures, Inc.

Tal Zaks, MD, PhD
Chief Medical Officer, Moderna Therapeutics

Gil Bar-Nahum, PhD
Managing Director, Jefferies International

Simon Gisby
Managing Director, Deloitte Corporate Finance LLC

Michal Silverberg
Managing Director, Novartis Venture Fund

Prof. Dina Ben-Yehuda, PhD
Dean of the Hadassah-Hebrew University Faculty of Medicine

Prof. Ronit Satchi-Fainaro, PhD
Head, Cancer Angiogenesis and Nanomedicine Laboratory, Sackler Faculty of Medicine, Tel Aviv University

Prof. Jeffrey A. Sosman, MD
Director, Melanoma program, Director, Faculty Development, Co-Leader, Translational Research in Solid Tumors, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Marc Funk
COO & President, Lonza Pharma & Biotech

Dan Vesely
Co-founder, CliniCrowd, Partner at Sdemagroup

John D. Halamka, MD, MS
Chief Information Officer, Beth Israel Deaconess System

Joshua Milner, MD
Chief, Laboratory of Allergic Diseases, National Health Institute

Ziv Ofek
Founder and CEO, MDClone

Amir Magner

Ofer Tzadik
COO & President, TytoCare

Ariel Beery
CEO, MobileODT

Ran Shaul
Co-Founder and Chief Product Officer, K Health

Prof. Shai Shen-Orr
Chief Scientist, CytoReason; Faculty of Medicine, Technion

Prof. Zohar Yakhini
DNA Storage

Chris Adams, PhD, MBA
Chief Executive Officer, Cydan II Inc.

Prof. Anat Loewenstein MD, MHA
Head, Ophthalmology Division, Tel Aviv Medical Center

Prof. Ehud Assia, MD
Head, Ophthalmology Division, Meir Medical Center

Julia Hawkins
Partner, LocalGlobe

Daniel Fischer
Founder at Tevard Biosciences

Prof. Amir Lerman, MD
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN, USA

Peter H.J. van der Goes, Jr.
Head of Healthcare IT and Digital Health Banking, Goldman Sachs

Prof. Moshe Phillip
Director of the Institute for Endocrinology and Diabetes, Israel National Center for Childhood Diabetes

William Shen
Executive Director, Business Development, Bristol-Myers Squibb

Mark Carlton
CSO, Cerevance Therapeutics

Prof. Michael Hornberger
Head of Department of Medicine & Professor of Applied Dementia Research at the Norwich Medical School; Director of Aging Research in the Norfolk & Suffolk Mental Health Trust

Michael C. Irizarry
Vice-President of Early Phase Neurosciences, Eli Lilly

Yuval Mor
CEO, Beyond Verbal

Phil L’Huillier, PhD, MBA
Head, European Innovation Hub, MSD


In Cooperation with

Supported by


STC Sanford T. Colb & Co




Astra Zeneca
Johnson & Johnson
Bristol-Myers Squibb
Hogan Lovells
Yeda Research and Development


Latham & Watkins


Zag S&W International Law Firm

Official News Distributor


Media Partners

MedTech Strategist
Fierce Biotech
IVC Online
  • This field is for validation purposes and should be left unchanged.